NDC 73309-372-01 - Alendronate Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-372
- Requested NDC
- 73309-372-01
- Package NDCs from labels
- 73309-372-01
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2022-03-11
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alendronate Sodium - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2022-03-11 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-372-01 | Alendronate Sodium | 100 g in 1 JAR | POWDER | 100 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EXELAN PHARMACEUTICALS INC. | 91a0f73a-d8cd-4197-b431-40707a2150b9 | 2023-08-25 | Warnings, Adverse reactions | 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Proficient Rx LP | 6c4d13fb-490c-4ea9-9b04-003c8d8e9f0c | 2023-03-01 | Warnings, Adverse reactions | 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Amneal Pharmaceuticals of New York LLC | c23fb7fe-c6b9-4f77-bde7-992222b589d3 | 2021-02-02 | Warnings, Adverse reactions | 2UY4M2U3RA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.